Prevalence of MET exon 14-mutations or MET amplification in non-small cell lung cancer in Swiss patients

被引：0
|
作者：
Prince, S. Savic [1 ]
Bihl, M. [1 ]
Eppenberger-Castori, S. [1 ]
Matter, M. S. [1 ]
Zellweger, N. [2 ]
Rothschild, S. I. [2 ]
Bubendorf, L. [1 ]
机构：
[1] Univ Hosp Basel, Inst Med Genet & Pathol, Pathol, Basel, Switzerland
[2] Univ Hosp Basel, Dept Oncol, Basel, Switzerland
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4P
引用
收藏
页码：S700 / S700
页数：1
相关论文
共 50 条
  • [41] The landscape of MET exon 14 skipping mutations in non-small cell lung cancer patients identified by next-generation sequencing
    Chen Shi
    Gao Ning
    Zong Qinglan
    CANCER RESEARCH, 2024, 84 (06)
  • [42] Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With MET Exon 14 Skipping
    Hur, Joon Young
    Ku, Bo Mi
    Shim, Joon Ho
    Jung, Hyun Ae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    IN VIVO, 2020, 34 (03): : 1399 - 1406
  • [43] Characterization of MET exon 14 skipping in Chinese non-small cell lung cancer (NSCLC) patients.
    Zhang, Baihua
    Xia, Yu
    Zhang, Jiujin
    Yu, Jin
    Chen, Min
    Yao, Wei
    Zhao, Juan
    He, Jiqiang
    Mok, Tony S. K.
    Wang, Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] Immunotherapy for stage IV non-small cell lung cancer patients with MET exon 14 skipping mutation
    Kuon, J.
    Blasi, M.
    Shah, R.
    Christopoulos, P.
    Stenzinger, A.
    Kazdal, D.
    Herth, F. J.
    Heussel, C. P.
    Thomas, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 172 - 172
  • [45] Tepotinib: Management of Adverse Events in Patients With MET Exon 14 Skipping Non-Small Cell Lung Cancer
    Ahn, Linda
    Alexander, Terri
    Vlassak, Soetkin
    Berghoff, Karin
    Lemmens, Liesbeth
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2022, 26 (05) : 543 - 551
  • [46] Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors
    Makoto Nishio
    Terufumi Kato
    Ryo Toyozawa
    Toyoaki Hida
    Targeted Oncology, 2022, 17 : 597 - 604
  • [47] Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors
    Nishio, Makoto
    Kato, Terufumi
    Toyozawa, Ryo
    Hida, Toyoaki
    TARGETED ONCOLOGY, 2022, 17 (05) : 597 - 604
  • [48] Tepotinib for advanced non-small-cell lung cancer with MET exon 14 skipping mutations
    Blaszkowska, M.
    Specht-Szwoch, Z.
    Dziadziuszko, R.
    ESMO OPEN, 2022, 7 (02)
  • [49] MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
    Awad, Mark M.
    Oxnard, Geoffrey R.
    Jackman, David M.
    Savukoski, Daniel O.
    Hall, Dimity
    Shivdasani, Priyanka
    Heng, Jennifer C.
    Dahlberg, Suzanne E.
    Anne, Pasi A. J.
    Verma, Suman
    Christensen, James
    Hammerman, Peter S.
    Sholl, Lynette M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07) : 721 - +
  • [50] Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer
    Minne, Rachel L.
    Luo, Natalie Y.
    Traynor, Anne M.
    Huang, Minxuan
    Detullio, Luisina
    Godden, Jen
    Stoppler, Melissa
    Kimple, Randall J.
    Baschnagel, Andrew M.
    CLINICAL LUNG CANCER, 2024, 25 (06)
12345